
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Aldolase B CRISPR/Cas9 KO Plasmid (m) | sc-432929 | 20 µg | $397.00 |
Aldob encodes aldolase B, a glycolytic and fructolytic enzyme that cleaves fructose-1,6-bisphosphate and fructose-1-phosphate to generate triose phosphates, linking carbohydrate breakdown to downstream energy production and biosynthetic flux. In mouse, aldolase B activity is most prominent in hepatocytes and proximal renal tubule cells, supporting hepatic glucose homeostasis, fructose metabolism, and metabolic adaptation during fasting and feeding cycles. Disruption of ALDOB function is classically associated with impaired fructose handling and broader disturbances in glycolysis/gluconeogenesis balance, making it relevant for studying metabolic stress responses and hepatocyte physiology. Aldob also provides a tractable node for interrogating pathway crosstalk between glycolysis, gluconeogenesis, and fructose-driven signaling in liver-centered disease models.
Aldolase B CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Aldob gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Aldob together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Aldob open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Aldolase B protein expression.
This CRISPR knockout system enables efficient generation of Aldob-deficient cell models for investigation of Aldolase B signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.